Q1 Earnings Forecast for Hyperfine Issued By B. Riley

Hyperfine, Inc. (NASDAQ:HYPRFree Report) – Investment analysts at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of Hyperfine in a report issued on Wednesday, March 19th. B. Riley analyst Y. Zhi expects that the company will post earnings of ($0.12) per share for the quarter. B. Riley currently has a “Buy” rating and a $1.20 target price on the stock. The consensus estimate for Hyperfine’s current full-year earnings is ($0.57) per share. B. Riley also issued estimates for Hyperfine’s Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.13) EPS and FY2025 earnings at ($0.49) EPS.

Hyperfine (NASDAQ:HYPRGet Free Report) last released its earnings results on Monday, March 17th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.02. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. The firm had revenue of $2.32 million during the quarter, compared to analyst estimates of $2.30 million. During the same quarter in the previous year, the firm earned ($0.15) earnings per share.

A number of other equities analysts also recently commented on HYPR. Lake Street Capital started coverage on Hyperfine in a research note on Monday. They issued a “buy” rating and a $1.50 target price for the company. Wells Fargo & Company boosted their price objective on Hyperfine from $1.10 to $1.29 and gave the company an “equal weight” rating in a research report on Tuesday, March 18th.

Read Our Latest Stock Analysis on Hyperfine

Hyperfine Stock Up 1.2 %

Shares of NASDAQ:HYPR opened at $0.83 on Monday. The company has a market cap of $60.55 million, a PE ratio of -1.46 and a beta of 0.94. Hyperfine has a fifty-two week low of $0.76 and a fifty-two week high of $1.90. The firm has a 50-day simple moving average of $1.06 and a 200 day simple moving average of $1.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of HYPR. Geode Capital Management LLC increased its stake in shares of Hyperfine by 18.7% in the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company’s stock valued at $675,000 after purchasing an additional 98,335 shares during the period. Graypoint LLC acquired a new position in shares of Hyperfine during the fourth quarter worth approximately $44,000. Virtu Financial LLC bought a new position in Hyperfine in the 4th quarter worth approximately $25,000. Renaissance Technologies LLC increased its position in Hyperfine by 32.9% in the 4th quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock valued at $187,000 after acquiring an additional 52,500 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its stake in Hyperfine by 64.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock valued at $72,000 after acquiring an additional 32,093 shares in the last quarter. 15.03% of the stock is owned by institutional investors and hedge funds.

Hyperfine Company Profile

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Featured Articles

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.